未登录

S

Shilton Dhaver

Mansoura University

H指数:7

被引数:144

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prevalence and Associated Risk Factors of Type 2 Diabetes among Egyptian University Students

埃及大学生中2型糖尿病的患病率及其相关危险因素

Journal of Diabetology

IF0

2026-01-010

PRE

Long-Term Effects of Intensive Lifestyle Intervention on Cardiometabolic Outcomes in Patients With Diabetes in Real-World Clinical Practice: A 15-Year Longitudinal Study

糖尿病患者在真实世界临床实践中，强化生活方式干预对心血管代谢结局的长期影响：一项15年纵向研究

Journal of Diabetes

IF3.7

2025-11-050

OAAI

Is Weight Loss the Main Driver for A1C Improvement by Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists? A 2.5-Year Analysis in Real-World Clinical Practice

减肥是胰高血糖素样肽1 (GLP-1) 受体激动剂改善A1C的主要驱动力吗？现实世界临床实践中的2.5年分析

JOURNAL OF DIABETES

IF3.7

2025-01-230

OA

Long-Term Improvement in Renal Function following Intensive Lifestyle Intervention in Patients with Diabetes and Obesity-A 15-Year Longitudinal Study

IF7.5

2024-06-140

PRE

The Effect of Structured Intensive Lifestyle Intervention on Muscle Mass in Patients with Type 2 Diabetes Receiving GLP-1 Receptor Agonists

IF7.5

2024-06-140

PRE

Evaluation of hybrid closed-loop insulin delivery system in type 1 diabetes in real-world clinical practice: One-year observational study

1型糖尿病患者混合闭环胰岛素给药系统的临床实践评价: 为期一年的观察性研究

WORLD JOURNAL OF DIABETES

IF4.6

2024-03-150

OAAI

The Long-Term Effect of Glucagon-Like Peptide 1 Receptor Agonists on Glycemic Control Is Predominantly Related to Weight Loss

IF7.5

2023-06-230

PRE

Diabetes Remission Outcomes Protocol (DROP)-Early Observation

IF7.5

2023-06-200

PRE

Effect of Intensive Lifestyle Intervention on Renal Function in Patients with Diabetes and Obesity-A 10-Year Longitudinal Study

IF7.5

2023-06-200

PRE

Long-Term Effects of Intensive Lifestyle Intervention in Real-World Clinical Practice on Cardiometabolic Outcomes in Patients with Diabetes-A 15-Year Longitudinal Study

IF7.5

2023-06-200

PRE

Prevalence of Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Patients with Type 1 Diabetes

IF7.5

2023-06-200

PRE

Relationship between Glycemic Control, Body Weight, and Nonalcoholic Fatty Liver Disease in Patients with Type 1 Diabetes

IF7.5

2023-06-201

PRE

Long-term effect of intensive lifestyle intervention on cardiometabolic risk factors and microvascular complications in patients with diabetes in real-world clinical practice: a 10-year longitudinal study

BMJ OPEN DIABETES RESEARCH & CARE

IF4.1

2023-05-229

OAAI

Magnitude of A1C improvement in relation to baseline A1C and amount of weight loss in response to intensive lifestyle intervention in real-world diabetes practice: 13 years of observation

JOURNAL OF DIABETES

IF3.7

2023-05-162

OA

Hybrid model of intensive lifestyle intervention is potentially effective in patients with diabetes & obesity for post-COVID era

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2023-01-178

OAAI

Almond Milk Has No Additional Benefits over 2% Milk on Postprandial Glycemia, Lipidemia, and Gastrointestinal Hormones in Patients with Type 2 Diabetes

IF7.5

2022-06-010

PRE

Moderate-to-Advanced Liver Fibrosis Is Common in Patients with Type 1 Diabetes (T1D) and Nonalcoholic Fatty Liver Disease (NAFLD)

IF7.5

2022-06-010

PRE

In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity

THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM

IF4.6

2022-04-1813

OAAI

Evaluation of Hybrid Closed-Loop Insulin Delivery System for Patients with Type 1 Diabetes in Real-World Clinical Practice: A One-Year Qualitative Observational Study

IF7.5

2020-06-011

PRE

Early Independent View of Quality of Life in Patients with Type 1 Diabetes Using Hybrid Closed-Loop Insulin Delivery System in Real-World Clinical Practice

IF7.5

2019-06-011

PRE